当前位置: X-MOL 学术J. Natl. Cancer Inst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The effect of metformin vs placebo on sex hormones in CCTG MA.32.
Journal of the National Cancer Institute ( IF 10.3 ) Pub Date : 2020-06-04 , DOI: 10.1093/jnci/djaa082
Isabel Pimentel 1 , Bingshu E Chen 2 , Ana Elisa Lohmann 3 , Marguerite Ennis 4 , Jennifer Ligibel 5 , Lois Shepherd 6 , Dawn L Hershman 7 , Timothy Whelan 8 , Vuk Stambolic 9 , Ingrid Mayer 10 , Timothy Hobday 11 , Julie Lemieux 12 , Alastair Thompson 13 , Priya Rastogi 14 , Karen Gelmon 15 , Daniel Rea 16 , Manuela Rabaglio 17 , Susan Ellard 18 , Mihaela Mates 19 , Philippe Bedard 9 , Lacey Pitre 20 , Theodore Vandenberg 21 , Ryan J O Dowling 9 , Wendy Parulekar 22 , Pamela J Goodwin 23
Affiliation  

Metformin has been associated with lower breast cancer risk and improved outcomes in observational studies. Multiple biologic mechanisms have been proposed, including a recent report of altered sex hormones (SHs). We evaluated the effect of metformin on SHs in MA.32, a phase III trial of nondiabetic BC subjects randomized to metformin or placebo.

中文翻译:

CCTG MA.32 中二甲双胍与安慰剂对性激素的影响。

在观察性研究中,二甲双胍与降低乳腺癌风险和改善预后相关。人们已经提出了多种生物学机制,包括最近关于性激素(SH)改变的报告。我们在 MA.32 中评估了二甲双胍对 SH 的影响,这是一项随机接受二甲双胍或安慰剂的非糖尿病 BC 受试者的 III 期试验。
更新日期:2020-06-04
down
wechat
bug